24 May 2013
Keywords: generics, firms, take, merck, co, pepcid, finally
Article | 17 April 2001
Merck & Co has finally lost patent protection on its gastrointestinaldrug Pepcid (famotidine) in the USA, with a string of companies ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
17 April 2001
18 April 2001
23 May 2013
© 2013 thepharmaletter.com